These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9559191)

  • 1. Cost-effective management of patients with dyspepsia.
    Levy M; Evans MF
    Can Fam Physician; 1998 Mar; 44():515-7. PubMed ID: 9559191
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
    Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
    Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
    Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.
    Shorr AF; Susla GM; Kollef MH
    Crit Care Med; 2004 Jan; 32(1):137-43. PubMed ID: 14707572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
    Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
    Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do cost-effectiveness analyses cause you dyspepsia?
    Ganiats TG
    J Fam Pract; 1997 Jun; 44(6):541-2. PubMed ID: 9191625
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years.
    Hatten AL; Gatchel RJ; Polatin PB; Stowell AW
    Clin J Pain; 2006 Oct; 22(8):700-11. PubMed ID: 16988566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. Is therapy based on endoscopy results better than empiric therapy for dyspepsia?
    Rich K; Safranek S; Malaty W
    J Fam Pract; 2005 Aug; 54(8):725-6. PubMed ID: 16061065
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.
    Turner DA; Paul S; Stone MA; Juarez-Garcia A; Squire I; Khunti K
    Heart; 2008 Dec; 94(12):1601-6. PubMed ID: 18450843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating dyspepsia: new OTC drug changes the economic picture.
    Dis Manag Advis; 2003 Oct; 9(10):133-4, 129. PubMed ID: 14679871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current guidelines for dyspepsia management.
    Ford AC; Moayyedi P
    Dig Dis; 2008; 26(3):225-30. PubMed ID: 18463440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The health economics of Helicobacter pylori infection.
    Moayyedi P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
    Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
    J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treat the patients' main dyspepsia complaint, not the ROME criteria.
    Chiba N
    Am J Gastroenterol; 2004 Jun; 99(6):1059-62. PubMed ID: 15180725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Approaches to diagnosis and treatment of dyspepsia].
    Jarbøl DE; Kjeldsen HC; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2004 Sep; 166(39):3385-8. PubMed ID: 15515390
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden.
    Kasteng F; Erlanson M; Hagberg H; Kimby E; Relander T; Lundkvist J
    Acta Oncol; 2008; 47(6):1029-36. PubMed ID: 18607857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational prescribing: practice audit and drug switch in dyspepsia management.
    Dott AG; Johnson L
    Int J Clin Pract; 1999 Dec; 53(8):599-603. PubMed ID: 10692753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.